Long Covid – can we weaken its grip?
#LongCovid is now affecting over 2 million people in the UK, a "mass disabling event" harming health and livelihoods. In the US, where it is reported over 20 million are afflicted with the condition, Long Covid is being described as the “next public health disaster”...
Were White House COVID victims lulled into false sense of security by current antigen tests?
Last week’s announcement that the most powerful man in the world had contracted COVID-19 calls into question the effectiveness of the White House testing regime.Screening with a test upon entry to the Rose Garden ‘super-spreader’ event on Sep 26th was clearly used as...
Hunting down the virus in the community will help resolve lab-based logjams and avoid lockdowns
The UK’s COVID-19 testing capacity has grown enormously over the past few months, but recent demand has grown even faster. The news is full of complaints about distant appointment offers and delays in getting results, so much so that the DHSC is now being forced to...
Is Attomarker’s Triple Antibody Test for COVID-19 now the best by far?
A recent Guardian article from Birmingham University biostatistics Professor John Deeks -https://bit.ly/34X9e9r - warned against cutting scientific corners in the pursuit of the ultimate COVID-19 antibody test. It had become apparent that the ‘98% sensitivity’...
Professor Andrew Shaw interviewed on television about Attomarker’s Triple Antibody Test
Attomarker’s Triple Antibody Test for COVID-19 authorised by the MHRA following positive trial results at St Thomas’ London
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Attomarker’s next-generation Triple Antibody Test for use in the UKThe Attomarker test detects antibodies to three different COVID-19 proteins in seven...
Attomarker’s rapid antibody technology has shown promising results in understanding COVID-19 in tests at St Thomas’ Hospital, London
Testing for COVID-19 currently relies on detecting virus RNA in a swab sample from the patient’s throat or nose. Laboratory analysis tells you if you have the virus where you were swabbed. It does not tell you if you have the...
COVID-19 – Attomarker technology currently being tested at St Thomas’s Hospital, London
Attomarker is supporting Professor Andrew Shaw’s research group at the University of Exeter in a series of important experiments to understand patient responses to the covid-19 coronavirus. Attomarker technology will allow...
The Dangers of Superbugs
NESTA, the organisers of the Longitude Prize, have produced a short film about the dangers of growing antibiotic resistance, especially in India. Professor Andrew Shaw, who was invited to the Superbugs Round Table and Exhibition...
Theranos is one to forget. Attomarker is one to remember. So why are they both ‘Ones to Watch’?
On the eve of 2020, The London Times published its annual assessment of key figures who they predicted would shape the business world in 2020 - the Ones to Watch “as we enter a new decade that could herald dramatic change”. Along...
